medical news

Tavanta Therapeutics Announces New Preclinical Data for its Cystic Fibrosis Candidate TAVT-135 at Two Prominent Scientific Conferences

KING OF PRUSSIA, PA — Tavanta Therapeutics announced presentations of new preclinical data for TAVT–135, a novel inhaled chloride ion transporter in development for pan-genotypic treatment of cystic fibrosis (CF). …

Tavanta Therapeutics Announces New Preclinical Data for its Cystic Fibrosis Candidate TAVT-135 at Two Prominent Scientific Conferences Read More